Corporate Corruption News Articles
Below are key excerpts of revealing news articles on corporate corruption from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.
You've heard those hospital horror stories where the surgeon removes the wrong body part or operates on the wrong patient. Even scarier, perhaps, is a new study in the latest edition of BMJ suggesting most medical errors go unobserved, at least in the official record. In fact, the study, from doctors at Johns Hopkins, suggests medical errors may kill more people than lower respiratory diseases like emphysema and bronchitis do. That would make these medical mistakes the third leading cause of death in the United States. That would place medical errors right behind heart disease and cancer. Through their analysis of four other studies examining death rate information, the doctors estimate there are at least 251,454 deaths due to medical errors annually in the United States. The authors believe the number is actually much higher, as home and nursing home deaths are not counted in that total. This is a much greater number than a highly cited 1999 study from the Institute of Medicine that put the number in the 44,000 to 98,000 range. Other studies have put estimates closer to 195,000 deaths a year. The U.S. Department of Health and Human Services Office of the inspector general in 2008 reported 180,000 deaths by medical error among Medicare patients alone. Dr. Martin Makary and Dr. Michael Daniel, who did the study, hope their analysis will lead to real reform in a health care system they argue is letting patients down.
Note: The above article does not mention prescription drug deaths. This is surprising, as prescription drugs were reported to have caused 123,000 deaths and 800,000 adverse patient outcomes such as disability in the US in 2014 alone. Read also the revealing comments of Marcia Angell, former editor-in-chief of the New England Journal of Medicine, on the massive corruption she found in the health industry. Then explore the excellent, reliable resources provided in our Health Information Center.
There arent many things upon which Hillary Clinton and Donald Trump agree. But the candidates for president share an affinity for the same ... office building in Wilmington. Famous for helping tens of thousands of companies avoid hundreds of millions of dollars in tax ... 1209 North Orange is home to Apple, American Airlines, Coca-Cola, Walmart and dozens of other companies. Being registered in Delaware lets companies take advantage of strict corporate secrecy rules, business-friendly courts and the Delaware loophole, which ... is said to have cost other states more than $9bn in lost taxes over the past decade. Both ... Hillary Clinton and Donald Trump have companies registered at 1209 North Orange, and have refused to explain why. Clinton, who has repeatedly promised that as president she will crack down on outrageous tax havens and loopholes, [has] collected more than $16m in public speaking fees and book royalties in 2014 through the doors of 1209. Bill Clinton set up WJC LLC, a vehicle to collect his consultation fees, at the same address in 2008. The Clintons companies share the office with several of Trumps companies. They include Trump International Management Corp and several companies that form part of ... a Trump partnership to develop more than $1bn worth of luxury condos on the west side of Manhattan. Of the 515 companies on Trumps official Federal Election Commission (FEC) filing, 378 are registered in Delaware.
Note: The above article adds to the evidence that the US, which ranks third in the world in financial secrecy, is a one-party state. For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and in the financial industry.
A USA Today analysis of more than 1,000 American-based companies registered by Mossack Fonseca, the law firm at the heart of the Panama Papers leak, casts the United States openly into an uncomfortable role: an offshore haven of corporate secrecy for wealthy business operations across the globe. Both Nevada and Wyoming have become secretive havens much like Bermuda and Switzerland have long been. And at least 150 companies set up by Mossack Fonseca in those states have ties to major corruption scandals in Brazil and Argentina. The corporate records of 1,000-plus Nevada business entities linked to the Panamanian law firm reveal layers of secretive ownership, with few having humans' names behind them, and most tracing back to a tiny number of overseas addresses. For about 700 of the American shell companies, the corporate officers are business entities rather than people, meaning no individual is linked to the Nevada firm in state records. Matthew Gardner, executive director of the Institute on Taxation and Economic Policy, [said], We should be thinking about this as a very American problem, and a problem that arguably is worse here in the states than it is in Panama. In Wyoming, where Mossack Fonseca has also registered about two dozen companies, corporations are even harder to trace. Mossack Fonseca defended its practices and said incorporating companies in different jurisdictions is the normal activity of lawyers and agents around the world.
Note: A 2015 Guardian newspaper article further describes how the US helps the super-rich hide assets. For more along these lines, see concise summaries of deeply revealing financial industry corruption news articles from reliable major media sources.
The Rockefeller Family Fund, a charity that supports causes related to the environment, economic justice and other issues, is liquidating its investments in fossil fuel companies, including Exxon Mobil. "While the global community works to eliminate the use of fossil fuels, it makes little sense - financially or ethically - to continue holding investments in these companies," the fund said. In announcing its decision, the Rockefeller fund attacked Exxon for what it called the company's "morally reprehensible conduct," alluding to allegations that the company has hidden evidence that fossil fuels contribute to climate change. "Evidence appears to suggest that the company worked since the 1980s to confuse the public about climate change's march, while simultaneously spending millions to fortify its own infrastructure against climate change's destructive consequences and track new exploration opportunities as the Arctic's ice receded," the fund said. New York State Attorney General Eric Schneiderman is said to have launched an investigation last fall into whether Exxon misled the public and investors about ... climate risks. California Attorney General Kamala Harris is also reportedly looking into whether Exxon lied about climate change. The probes followed a report by InsideClimate News ... claiming that Exxon sought to undermine scientific evidence that pointed to the growing threat of climate change.
Note: The Rockefeller Brothers Fund announced its fossil fuel divestment in 2014. For more along these lines, see concise summaries of deeply revealing news articles on climate change and the corruption of science from reliable major media sources.
New research suggests that Splenda - an artificial sweetener recently considered safe - may contribute to serious health problems like cancer. The study, published in the International Journal of Occupational and Environmental Health, found that mice fed sucralose daily throughout their lives developed leukemia and other blood cancers. In response to the findings, the Center for Science in the Public Interest - a nutrition watchdog group that assesses the safety of food additives - has now formally recommended that consumers avoid the sweetener. That's a big deal, considering that until 2013, they'd rated the additive as "safe." This new evidence was especially powerful because it was funded without special interests in mind, explains Lisa Lefferts, MSPH, senior scientist at the CSPI. "For most food additives, the safety studies are conducted by the manufacturers who have financial incentives," Lefferts says. Even if you discount this new mouse study, you'll still find plenty of reasons to skip out on sucralose. A growing body of research shows that artificial sweeteners may actually cause weight gain, not weight loss. One study found drinking diet soda was linked to increased belly fat; in another, each daily can was associated with a 41% jump in obesity risk. Sucralose has even been shown to mess with your blood sugar and insulin levels, causing spikes and dips that could lead to cravings later on. The bottom line: the scientists at the CSPI firmly believe you should steer clear of sucralose.
Note: Food additive manufacturers use the same deceptive tactics that Big Tobacco was found guilty of. For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.
Japan's prime minister at the time of the 2011 earthquake and tsunami has revealed that the country came within a paper-thin margin of a nuclear disaster requiring the evacuation of 50 million people. In an interview with The Telegraph ... Naoto Kan described the panic and disarray at the highest levels of the Japanese government as it fought to control multiple meltdowns at the crippled Fukushima Daiichi nuclear power station. He said he considered evacuating the capital, Tokyo, along with all other areas within 160 miles of the plant, and declaring martial law. Mr Kan admitted he was frightened and said he got no clear information out of Tepco, the plants operator. He was very shocked by the performance of Nobuaki Terasaka, his own governments key nuclear safety adviser. We asked him do you know anything about nuclear issues? And he said no, I majored in economics. Another member of Mr Kans crisis working group, the then Tepco chairman, Tsunehisa Katsumata, was last week indicted on charges of criminal negligence for his role in the disaster. Mr Kan lost the prime ministership later in 2011. The former leader said that a lot of the accident was caused before March 11 by the complacency and misjudgment of Tepco, a verdict echoed by the official inquiry, which dubbed the nuclear accident a man-made disaster. The criminal investigation which led to last weeks charges against Mr Katsumata and two other Tepco managers found that they had known since June 2009 that the plant was vulnerable.
Note: For more along these lines, see concise summaries of deeply revealing news articles on the Fukushima Nuclear Plant disaster.
Bill and Melinda Gates are facing calls for their philanthropic Foundation, through which they have donated billions worldwide, to be subject to an international investigation. The Gates Foundation is about benefiting big business, especially in agriculture and health, through its ideological commitment to promote neoliberal economic policies and corporate globalisation, according to [a] report published by the campaign group Global Justice Now. The report accuses the Gates Foundation of [turning] basic needs into commodities controlled by the market. The report is critical of the close working relations between the Foundation and major international pharmaceutical corporations. It accuses the Gates Foundation of promoting specific priorities through agriculture grants, some of which undermine the interests of small farmers. These include promoting industrial agriculture, use of chemical fertilisers and expensive, patented seeds, and a focus on genetically modified seeds. The criticism echoes the accusations made by the Indian scientist Vandana Shiva who called the Gates Foundation the greatest threat to farmers in the developing world. The Foundations emphasis on technological solutions often ignores real solutions involving social and economic justice. This cannot be given by donors in the form of a climate-resilient crop or cheaper smartphone, but must be about systemic social, economic and political change issues not represented in the foundations funding priorities.
Note: The Gates Foundation is heavily invested in GMO giants like Monsanto. It also provided $5 million to Oxitec, a company criticized for secretly releasing GM mosquitoes into the wild in 2009. Oxitec was purchased last August by biotech giant Intrexon for $160 million. By December, the Zika virus was all over the news and Intrexon was ramping up production of these GM insects to "fight Zika" in Brazil. For more along these lines, see concise summaries of deeply revealing corporate corruption news articles from reliable major media sources.
After Martin Shkreli raised the price of anti-parasitic drug Daraprim more than 50-fold to $750 a pill last year, he said he wasnt alone in taking big price hikes. The former drug executive was right. A survey of about 3,000 brand-name prescription drugs found that prices more than doubled for 60 and at least quadrupled for 20 since December 2014. Skyrocketing prices are getting increased scrutiny ahead of a U.S. congressional hearing this week: Democratic Representative Elijah Cummings, ranking member on a committee that is probing drug pricing, said Tuesday that pricing tactics are not limited to a few bad apples, but are prominent throughout the industry. The cost of many drugs [rises] at annual rates of more than 10 percent. Drugmakers raised the prices of products as wide-ranging as erectile dysfunction drug Viagra, heart treatments, dermatology medicine and even brands that long have lost their patents. While specialty companies have had the steepest hikes, giants such as Pfizer Inc. and GlaxoSmithKline Plc kept pushing through smaller rises. About 400 formulations of brand-name drugs went up at least 9.9 percent since early December. Valeant Pharmaceuticals International Inc., which in recent months has been under fire for its pricing was among the most aggressive, with 13 drugs that doubled or more since December 2014.
Note: For more excellent information on drug prices hikes, read this penetrating article in the Daily Beast. For more along these lines, see concise summaries of deeply revealing big pharma profiteering news articles from reliable major media sources.
Massachusetts Senator Elizabeth Warren issued a stinging broadside against federal prosecutors on Friday, charging U.S. courts with throwing the book at mixed-up teenagers, while letting wealthy corporate executives who commit much larger and sometimes deadly crimes off with essentially no chance of punishment. In a new report, Sen. Warrens office makes the case that CEOs and other top executives simply dont face the same legal consequences as ordinary Americans, releasing a list of what it claims are 20 examples of corporate criminal and civil cases that prosecutors failed to pursue to the full extent of the law last year. Among the cases: scandals ranging from General Motors years long cover up of ignition switch problems to currency manipulation by large banks (including Citigroup and J.P. Morgan), to a mine explosion that killed 29 people - the only instance of misconduct which led to a conviction of a corporate executive. Such selective application of the law undermines the governments moral authority: If justice means a prison sentence for a teenager who steals a car, but it means nothing more than a sideways glance at a CEO who quietly engineers the theft of billions of dollars, then the promise of equal justice under the law has turned into a lie, Warren charges in the report. Its not just a problem in the U.S. This week, U.K. prosecutors, after winning an initial conviction in their quest to prosecute bankers accused of fixing LIBOR - a key benchmark central to financial markets - failed to secure any further wins.
Note: Senator Elizabeth Warren was called "the champion of Main Street versus Wall Street" by the Boston Globe in 2014. For more along these lines, see concise summaries of deeply revealing news articles about corruption in government and in the corporate world.
Soon after launching a brutal air and ground assault in Yemen, the Kingdom of Saudi Arabia began devoting significant resources to a sophisticated public relations blitz. Elements of the charm offensive include the launch of a pro-Saudi Arabia media portal operated by high-profile Republican campaign consultants; a special English-language website devoted to putting a positive spin on the latest developments in the Yemen war; glitzy dinners with American political and business elites; and a non-stop push to sway reporters and policymakers. That has been accompanied by a spending spree on American lobbyists with ties to the Washington establishment. Saudi Arabia continues to be a leading driver of Sunni terror networks worldwide, including in Syria and Iraq. The Saudi Arabian government is currently supplying weapons to a Syrian rebel coalition that includes the Nusra Front, al Qaedas affiliate in the region. Private donors in Saudi Arabia have also worked as fundraisers for the Islamic State, or ISIS. And there is a renewed, bipartisan push by lawmakers to declassify the 28 pages of the 9/11 Commission Report, a censored section that reportedly relates to Saudi state support for al Qaedas operation. In September, the Kingdom helped sponsor opulent galas for Washingtons business elite at the Ritz Carlton and the Andrew Mellon Auditorium. The events were attended by King Salman, along with the chief executives of General Electric and Lockheed Martin, the chairman of Marriott International, and prominent think tank officials.
Note: A carefully researched report on the covert origins of ISIS suggests the creation of terrorists is useful for Washington's elite. A document that is reported to connect Saudi money to 9/11 remains classified. For more along these lines, see concise summaries of deeply revealing news articles about government corruption and media manipulation.
According to the New York Department of Financial Services, a banking regulator, Goldman hired Rohit Bansal from the Federal Reserve Bank of New York in May 2014, "in large part for the regulatory experience and knowledge he had gained while working at the New York Fed." Goldman hired Bansal despite the fact that he had been forced to resign from the Fed for breaking the rules there. Once at Goldman, Bansal was instructed to work on a bank that he had supervised while at the Fed, despite explicit prohibitions against him doing so, NYDFS said. Bansal later used confidential information, some of which he obtained from his prior employment at the NY Fed and some of which he obtained from from a former NY Fed colleague, in his work on the bank. To resolve the matter, Goldman has agreed to pay $50 million and accept a three-year "voluntary abstention" from accepting new consulting engagements of NYDFS regulated entities. Goldman also agreed to admit that a former employee engaged in the criminal theft of confidential information and that Goldman management "failed to effectively supervise its employee to prevent this theft from occurring," NYDFS said. In September 2014, for example, Bansal attended the birthday dinner of a former Fed colleague at Peter Luger's. Immediately after the dinner, Bansal emailed his boss at Goldman "divulging confidential information concerning the regulated entity, specifically, the relevant component of the upcoming examination rating," NYDFS said.
Note: For more along these lines, see concise summaries of deeply revealing news articles about corruption in government and in the financial industry.
A former Goldman Sachs banker suspected of taking confidential documents from a source inside the government has agreed to plead guilty, a rare criminal action on Wall Street, where Goldman itself is facing an array of regulatory penalties over the leak. The banker and his source, who at the time of the leak was an employee at the Federal Reserve Bank of New York, one of Goldmans regulators, will accept a plea deal from federal prosecutors that could send them to prison for up to a year. Under a tentative deal ... Goldman would pay a fine of $50 million. For Goldman and the New York Fed, the case is likely to give new life to an embarrassing episode that illustrated the blurred lines between their institutions. Perhaps more than any other bank, Goldman swaps employees with the government, earning it the nickname Government Sachs. While the so-called revolving door is common on Wall Street, the investigation [affirms] the publics concerns that regulators and bankers, when intermingled, occasionally form unholy alliances. The Goldman banker, Rohit Bansal, previously spent seven years as a regulator at the New York Fed.
Note: For more along these lines, see concise summaries of deeply revealing news articles about corruption in government and in the financial industry.
Law firms around the United States are lining up plaintiffs for what they say could be "mass tort" actions against agrichemical giant Monsanto Co that claim the company's Roundup herbicide has caused cancer in farm workers and others exposed to the chemical. The latest lawsuit was filed Wednesday in Delaware. The lawsuit is similar to others filed last month in New York and California accusing Monsanto of long knowing that the main ingredient in Roundup, glyphosate, was hazardous. Monsanto "led a prolonged campaign of misinformation to convince government agencies, farmers and the general population that Roundup was safe," the lawsuit states. The litigation follows the World Health Organization's declaration in March that there was sufficient evidence to classify glyphosate as "probably carcinogenic to humans." "We can prove that Monsanto knew about the dangers of glyphosate," said Michael McDivitt, whose Colorado-based law firm is putting together cases for 50 individuals. Roundup ... brought Monsanto $4.8 billion in revenue in its fiscal 2015. But questions about Roundup's safety have dogged the company for years. Attorneys who have filed or are eying litigation cited strong evidence that links glyphosate to non-Hodgkin lymphoma. Monsanto is also fending off claims over its past manufacturing of polychlorinated biphenyls (PCBs), which the WHO classifies as known carcinogens. At least 700 lawsuits against Monsanto or Monsanto-related entities are pending.
Note: It's interesting to note that a Google search shows almost no major media picked up this key news. Read how the EPA used industry studies while ignoring independent studies to declare Roundup safe. Read also an excellent mercola.com article titled "GMO cookie is crumbling." Monsanto is trying to stop the state of California from listing Glyphosate as carcinogenic. For more along these lines, see concise summaries of deeply revealing GMO news articles from reliable major media sources.
Monsanto Co.s undisclosed recruitment of scientists from Harvard University, Cornell University and three other schools to write about the benefits of plant biotechnology is drawing fire from opponents. Monsanto says its in regular contact with public-sector scientists as it tries to elevate public dialog on genetically modified organisms, or GMOs. U.S. Right to Know, a nonprofit group funded by the Organic Consumers Association that obtained e-mails under the Freedom of Information Act, says correspondence revealing Monsantos actions shows the corporate control of science and how compliant some academics are. The articles have become the latest flashpoint in an information war being waged over plant biotechnology. The articles in question appeared on the Genetic Literacy Projects website in a series called GMO - Beyond the Science. Eric Sachs, who leads Monsantos scientific outreach, wrote to eight scientists to pen a series of briefs aimed at influencing public policy, GM crop regulation and consumer acceptance. Five of them obliged. University of Florida Professor Kevin Folta said he agreed to write Anti-GMO Activism and Its Impact on Food Security because communicating science to the public is his job. Folta has faced public criticism since the New York Times ... reported last month about his communications with Monsanto and a $25,000 donation to the science communication program he runs.
Note: For more along these lines, see concise summaries of deeply revealing news articles about the corruption of science and the controversy surrounding GMOs.
In 2001, a "landmark" study published in the prestigious Journal of the American Academy of Child and Adolescent Psychiatry purported to show the safety and effectiveness of using a common antidepressant to treat adolescents. The original published findings were biased and misleading. Known as Study 329, the randomised controlled trial ... was funded by SmithKline Beecham now GlaxoSmithKline (GSK) the manufacturer of paroxetine. The research has been repeatedly criticised, and there have been numerous calls for it to be retracted. To re-analyse the evidence of effectiveness and safety of paroxetine, we used documents posted online by GSK. We also had access to other publicly available documents and individual participant data. We found that paroxetine [Paxil] was no more effective than a placebo, which is the opposite of the claim in the original paper. We also found significant increases in harms with both paroxetine and imipramine, [another antidepressant]. Compared with the placebo group, the paroxetine group had more than twice as many severe adverse events, and four times as many psychiatric adverse events, including suicidal behaviours and self-harm. And the imipramine group had significantly more heart problems. Our re-analysis ... identified ten strategies used by researchers in this clinical trial to minimise apparent harms. More importantly, our findings show influential peer-reviewed research published in leading medical journals can be seriously misleading.
Note: We all know that clinical trial are skewed when they are sponsored by drug companies, but here is undeniable proof of this published in the UK's most respected medical journal. See this key study on the website of the British Medical Journal. Then don't miss that amazing documentary "Bought" available for free viewing.
A former C.I.A. officer with experience in Turkey wrote a provocative essay this summer about the deep state. The phrase refers to a parallel secret government embedded in the military and intelligence services, whose purpose is to provide a check on electoral democracy. The essay, written by Philip Giraldi ... called the American deep state of today an unelected, unappointed, and unaccountable presence within the system that actually manages what is taking place behind the scenes. The American deep state of his description consists of ... Capitol Hill aides and legislators who cash in as lobbyists; former politicians who earn millions speaking to banks ... technocrats who ricochet between Goldman Sachs and the Treasury Department; billionaire kingmakers dangling political donations; thinkers whose tanks are financed by corporations with a financial stake in their research. The deep state metaphor seems to be ascendant as a way to explain present American realities. The writer Peter Dale Scott ... last year published a similarly minded book called The American Deep State, which emphasized the role of security contractors, oil companies and financial firms. Meanwhile, Mike Lofgren, a Republican who spent 28 years as a congressional aide before quitting in 2011, has used deep state to describe a subterranean cross-party consensus on issues like financialization, outsourcing, privatization ... from which the public is distracted by above-ground debates over diversionary social issues.
Note: Read an incisive essay by "deep state" author Prof. Peter Dale Scott showing how big money continues to run the Trump team, just as it has all previous government of both parties. For more along these lines, see concise summaries of deeply revealing news articles on secrecy and lies in government and industry.
What if your life depended on a drug that cost half a million dollars a year, every year, for the foreseeable future? That's the price of Soliris, one of the world's most expensive drugs. It is the only medicine available for people suffering from two ultra-rare diseases. And for both diseases, Soliris is not a cure, but ... patients can go back to living normal lives. But only if they can get the drug, and many can't, because it is priced beyond the reach of almost everyone. So how can one drug cost more than the annual income of all but a tiny percentage of households? The reason is ... orphan drug pricing, where actual research and development costs are carefully guarded secrets known only to drug company executives. "Orphan" in this context refers to rare diseases [for which] the patient population was too small to attract the interest of drug companies. But now medications to treat these ultra-rare diseases are becoming more profitable than traditional drugs, because of ... a business model based on extreme pricing. The extreme prices of these new orphan drugs are largely arbitrary, and have very little to do with the development and manufacturing costs. Most drugs are based on scientific discoveries made in publicly funded research labs, by academic scientists. In case of Soliris, most of the research and development was done by university researchers working in academic laboratories supported by public funds. Soliris is Alexion's only drug, but it's a blockbuster, earning revenues of more than $6 billion in just eight years, and making Alexion one of the fastest growing companies in the world.
Note: For more along these lines, see concise summaries of deeply revealing news articles on pharmaceutical corruption from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.
Twenty of the world's biggest banks have paid more than $235 billion in fines and compensation in the last seven years for a litany of misdeeds. The scale of the payouts, equivalent to the annual economy of Greece or Portugal, has hampered banks' efforts to rebuild capital, reduced dividends for investors and cut the amount firms are able to lend. The misconduct bill is expected to rise by tens of billions more dollars, and many politicians, regulators and industry observers said more needs to be done. Mark Taylor, dean of the business school at the University of Warwick in central England [says] bonuses are too high, there is little threat of jail for wrongdoers and bosses are not held responsible. "The problem is the incentives for cheating markets is massive. If you can shift a rate fractionally you can make millions and millions of dollars for your bank and then for bonuses. "Once senior executives feel they are personally at risk if the culture doesn't change, and individual traders feel they are at risk of being put in prison, then you'll get a culture change," he said. Despite the scale of fines and compensation paid by banks, relatively few individuals have been punished. Data compiled by Reuters ... showed U.S. banks have paid $140 billion in litigation and compensation for mortgage related issues since 2008. Bank of America has paid out twice as much as any other bank in settlements and compensation, with a bill of almost $80 billion.
Note: Big bank settlements often amount to "cash for secrecy" deals that are ultimately profitable for banks. For more along these lines, see concise summaries of deeply revealing news articles about corruption in government and in the financial industry.
Illegal and unethical behaviour on Wall Street and in the City of London isn't just the work of a few bad apples - it's commonplace, according to new research. More than one in five financial services employees in America and the UK have seen their co-workers breaking the law or engaging in misconduct, a survey of more than 1,200 workers has found. Many feel under pressure to break the rules, believing it is a necessary part of getting ahead. Those at the top of the food chain are even more likely to have seen misconduct, with over a third of those earning more than $500,000 a year say they "have witnessed or have first hand knowledge of wrongdoing in the workplace". The University of Notre Dame and law firm Labaton Sucharow, which published the report, said it showed that bankers had failed to improve behaviour, despite billions of dollars in fines, and new regulations threatening jail. "Despite the headline-making consequences of corporate misconduct, our survey reveals that attitudes toward corruption within the industry have not changed for the better," the report's authors said. The researchers ... interviewed 1,223 banking and financial services workers. The research comes the day before five banks are expecting fines worth more than $6bn related to foreign exchange manipulation. Those questioned in the survey were also asked about whistleblowing practices, and 16pc said that corporate policies barred them from reporting illegal activity to authorities.
Note: For more along these lines, see concise summaries of deeply revealing banking corruption news articles from reliable major media sources.
The issues surrounding G.M.O.s - genetically modified organisms - became more complicated last week when the International Agency for Research on Cancer declared that glyphosate, the active ingredient in the widely used herbicide Roundup, probably causes cancer in humans. Two insecticides, malathion and diazinon, were also classified as "probable" carcinogens by the agency, a respected arm of the World Health Organization. Roundup, made by Monsanto for both home and commercial use, is crucial in the production of genetically engineered corn and soybean crops, so it was notable that the verdict on its dangers came nearly simultaneously with an announcement by the Food and Drug Administration that new breeds of genetically engineered potato and apple are safe to eat. Few people are surprised that an herbicide in widespread use is probably toxic at high doses or with prolonged exposure, circumstances that may be common among farmers and farmworkers. Nor is it surprising that it took so long - Roundup has been used since the 1970s - to discover its likely carcinogenic properties. There is a sad history of us acting as guinea pigs for the novel chemicals that industry develops. To date, G.M.O.s and other forms of biotech have done nothing but enrich their manufacturers and promote a system of agriculture that's neither sustainable nor for the most part beneficial. We don't need better, smarter chemicals along with crops that can tolerate them; we need fewer chemicals. There's no reason to put the general population, and particularly the farming population, at risk for the sake of industry profits.
Note: Monsanto's Roundup and the GMO crops that support its use are well-known by scientists to be a threat to public health. For more, see concise summaries of deeply revealing news articles on GMO risks and how these are covered up.
Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.
